Special Feature

User Panel

My Panel

My Panel

Bookmark Science Articles

Recent News
Bookmark / Share This Science Site

Aspirin and folic acid for the prevention of recurrent colorectal adenomas.

Aspirin and folic acid for the prevention of recurrent colorectal adenomas. Research Abstract Details 

Research Abstract Table of Contents

Jump to the:

  • Abstract Text of This Paper
  • Journal Published
  • MeSH Keywords of This Abstract
  • Chemicals and Substances Used in this Paper
  • Grants and Granting Agency of this Research
  • Database Accession Numbers Used in this Paper
  • Related Papers
  • Related Research Tags
  • Rate this Research Paper
  • Aspirin and folic acid for the prevention of recurrent colorectal adenomas. Abstract Text:

    richard f a loganRichard F A Logan,matthew j graingeMatthew J Grainge,vic c shepherdVic C Shepherd,nicholas c armitageNicholas C Armitage,kenneth r muirKenneth R Muir, ,richard f a loganRichard F A Logan,matthew j graingeMatthew J Grainge,vic c shepherdVic C Shepherd,nicholas c armitageNicholas C Armitage,kenneth r muirKenneth R Muir, ,richard f a loganRichard F A Logan,matthew j graingeMatthew J Grainge,vic c shepherdVic C Shepherd,nicholas c armitageNicholas C Armitage,kenneth r muirKenneth R Muir, ,

    BACKGROUND & AIMS: Although observational studies have found regular aspirin use to be associated with a reduced risk of colorectal neoplasia, results from randomized trials using aspirin have been inconsistent. Dietary folate intake also has been found to be associated with a reduced risk of colorectal neoplasms in observational studies. METHODS: A multicenter, randomized, double-blind trial of aspirin (300 mg/day) and folate supplements (0.5 mg/day) to prevent colorectal adenoma recurrence was performed using a 2 x 2 factorial design. All patients had an adenoma (>/=0.5 cm) removed in the 6 months before recruitment and were followed-up at 4-month intervals with a second colonoscopy after approximately 3 years. The primary outcome measure was a colorectal adenoma diagnosed after baseline. RESULTS: A total of 945 patients were recruited into the study, of whom 853 (90.3%) underwent a second colonoscopy. In total, 99 (22.8%) of 434 patients receiving aspirin had a recurrent adenoma compared with 121 (28.9%) of 419 patients receiving placebo (relative risk, 0.79; 95% confidence interval [CI], 0.63-0.99). A total of 104 patients developed an advanced colorectal adenoma; 41 (9.4%) of these were in the aspirin group and 63 (15.0%) were in the placebo group (relative risk, 0.63; 95% CI, 0.43-0.91). Folate supplementation was found to have no effect on adenoma recurrence (relative risk, 1.07; 95% CI, 0.85-1.34). CONCLUSIONS: Aspirin (300 mg/day) but not folate (0.5 mg/day) use was found to reduce the risk of colorectal adenoma recurrence, with evidence that aspirin could have a significant role in preventing the development of advanced lesions.

    Aspirin and folic acid for the prevention of recurrent colorectal adenomas. Publishing Authors By Initials

    rf loganRF Logan,mj graingeMJ Grainge,vc shepherdVC Shepherd,nc armitageNC Armitage,kr muirKR Muir, ,rf loganRF Logan,mj graingeMJ Grainge,vc shepherdVC Shepherd,nc armitageNC Armitage,kr muirKR Muir, ,rf loganRF Logan,mj graingeMJ Grainge,vc shepherdVC Shepherd,nc armitageNC Armitage,kr muirKR Muir, ,

    For similar abstracts research abstracts see: abstracts research

    PUBMED ID PMID:

    MEDLINE DATE:

    Aspirin and folic acid for the prevention of recurrent colorectal adenomas. Journal Published:

    PUBLICATION TYPE: Research Support, Non-U.S. Gov

    Journal: Gastroenterology

    VOLUME: 134

    Page Numbers: 29-38

    Journal Abbreviation: Gastroenterology

    ISSN: 1528-0012

    DAY: 10

    MONTH: 10

    YEAR: 2007

    Aspirin and folic acid for the prevention of recurrent colorectal adenomas. Information

    Number of References:

    LANGUAGE: eng

    NlmUniqueID: 374630

    Aspirin and folic acid for the prevention of recurrent colorectal adenomas. Keywords Mesh Terms:

    KEYWORDS:

    MESH TERMS:

    Chemical & Substance for Abstract: Aspirin and folic acid for the prevention of recurrent colorectal adenomas. Information

    Substance Name:

    Registry Number:

    Grant and Affiliation Information for Aspirin and folic acid for the prevention of recurrent colorectal adenomas.

    AFFILIATION: Division of Epidemiology and Public Health, University of Nottingham, University Hospital, Nottingham, United Kingdom. Richard.Logan@nottingham.ac.uk

    Country: United States

    United States Research PublicationUnited States Research Publication

    AGENCY:

    GRANT:

    ACRONYM:

    MEDLINETA: Gastroenterology

    REFSOURCE:

    DATABASENAME:

    ACCESSION NUMBER:

    Number Hits: 0

    Aspirin and folic acid for the prevention of recurrent colorectal adenomas Related Publications

     

    Molecular Station USER Menu

    Welcome to Molecular Station!

    You have to register before you can post on our forums or use our advanced features. Register Now! Its Free and Fast!

    Already registered? Login now below.

    User Name:

    Password:

    Already registered and Forgot your password? Click below to recover it.

    Recover Lost Password

    Join now - it's fast and free!

    Molecular Station is THE largest network of researchers, scientists and science lovers anywhere!

    Research Terms of Usage and Disclaimer
    Home
    Features

    Protocols

    DNA Forum

    Science Forum

    DNA Forum
    Biology Forum

    Science News


    [CaRP] XML error: Invalid document end at line 2

    For more click here:Science News